(LEAD) Celltrion acquires U.S. biopharma plant from Eli Lilly to counter tariff threats
SEOUL, Sept. 23 (Yonhap) -- Celltrion Inc., South Korea's leading biopharmaceutical company, said Tuesday its U.S. subsidiary has signed a deal to acquire a U.S.


